Navigation Links
Purple tomatoes: The richness of antioxidants against tumors
Date:10/26/2008

Researchers from the John Innes Centre in Norwich, Great Britain, in collaboration with other European centres participating to the FLORA project, have obtained genetically modified tomatoes rich in anthocyanins, a category of antioxidants belonging to the class of flavonoids. These tomatoes, added to the diet of cancer-prone mice, showed a significant protective effect by extending the mice lifespan. The research has been published in the 26 October issue of Nature Biotechnology.

It is a remarkable step ahead in the study on antioxidants, particularly flavonoids, widely considered as a useful tool for preventing a large number of diseases, from cardiovascular disease to certain types of can-cer. The diet followed by the majority of people living in the Western world does not appear to be suffi-cient to guarantee an adequate intake of these substances, present in many fruits and vegetables such as berries. That is why the FLORA project aims at understanding their mechanisms trying to find new ways to increase their consumption.

Researchers from the John Innes Centre, coordinated by Cathie Martin, tried to step on it by putting on the lab bench a naturally anthocyanins-free product as tomato and engineering it to enhance its flavonoid content. In this way researchers have obtained an ideal model to study the effect of anthocyanins.

In order to obtain fruit particularly rich in anthocyanins, that has conferred a peculiar purple colour to the tomatoes, the British team has used two genes from the snapdragon flower: Delila and Rosea1. "Our insti-tute has a long standing interest in this plant that we use as a model to study flower development- says lead author Eugenio Butelli- The two genes we have isolated are responsible for flower pigmentation and, when introduced in other plants, turned out to be the perfect combination to produce anthocyanins, the same phytochemical found in blueberries. At a closer chemical analysis it
'/>"/>

Contact: Americo Bonanni
bonanni@filemazio.net
39-347-930-5981
Catholic University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Fried purple tomatoes
2. Purple extremist thrives under inhospitable conditions
3. Research shows Brazilian acai berry antioxidants absorbed by human body
4. Antioxidants could provide all-purpose radiation protection
5. Clemson chemists discover new way antioxidants fight debilitating diseases
6. Research identifies type of vaccine that holds promise in protecting against TB
7. Wielding microbe against microbe, beetle defends its food source
8. Vitiligo skin disorder could yield clues in fight against melanoma
9. Friendly bacteria protect against type 1 diabetes, Yale researchers find
10. Bats pick up rustling sounds against highway background noise
11. Vaccine against HER2-positive breast cancer offers complete protection in lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/5/2014)... 2014  Tute Genomics, a leader in cloud-based solutions ... A1 funding led by UK-based Eurovestech. Peak Ventures and ... investment round. "We are at a pivotal ... sequencing and seeks new approaches for the diagnosis, treatment ... MD MBA, and CEO of Tute Genomics. "One of ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... new study suggests that preterm infants may not be ... United Kingdom immunization schedule. The findings are reported in ... Vaccine Immunology . The study, conducted by researchers ... neonatal intensive care units. The survey found that preterm ...
... This release is available in German . ... and reliable testing of HIV inhibitors. This system was developed ... of Virology. At the heart of the system are cultured ... and that signal HIV infection by producing a red fluorescent ...
... has cheated on you for the umpteenth time and their ... researchers at Binghamton University, they may be right. The propensity ... In a first of its kind study, a team of ... in the laboratory of evolutionary anthropology and health at Binghamton ...
Cached Biology News:A powerful new technology to identify HIV inhibitors 2New study suggests that a propensity for 1-night stands, uncommitted sex could be genetic 2New study suggests that a propensity for 1-night stands, uncommitted sex could be genetic 3
(Date:12/22/2014)... DIEGO , Dec. 22, 2014 GenomeDx ... the Decipher Prostate Cancer Classifier, a genomic test for ... in node-negative, high-risk men managed by radical prostatectomy without ... radical prostatectomy is relatively uncommon, using tumor genomics to ... of metastatic disease is an important advance. The study ...
(Date:12/19/2014)... and Hershey, PA (PRWEB) December 19, 2014 ... BJCT), a leading developer and manufacturer of needle-free ... into an agreement with Immunomic Therapeutics, Inc. (“ITI”) ... needle-free injection device with its LAMP™ vaccine platform. ... option for an exclusive Worldwide license to the ...
(Date:12/19/2014)... CITY, Calif. , Dec. 19, 2014 Bina ... , USA) announced today that they have been acquired ... 1,2 is a privately held company that provides ... of next generation sequencing (NGS) data for the academic ... the Roche Sequencing Unit, and will continue to focus ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 LayerBio ... for ophthalmology and wound care. The National Eye Institute ... awarded LayerBio a Phase I SBIR grant to develop ... Cataracts are the most common cause of vision loss ... of blindness worldwide. According to Dr. Ken Mandell, LayerBio’s ...
Breaking Biology Technology:Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... Group Inc. (Nasdaq: GSIG ), a supplier of ... identified errors related to timing of the recognition of revenue ... during fiscal year 2006. The Audit Committee of the Board ... of potential adjustments resulting from the identified errors is material ...
... A Complimentary WebinarMOUNTAIN VIEW, Calif., March 30 , - TOPIC: ... current and potential impact on drug discovery, molecular, ... - WHEN: Tuesday, March 31, 2009, ... Online with free registration, - HOST: Christi ...
... provider of electronic informed consent software for clinical research trials ... Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical ... feasibility assessment, through clinical development to commercialization. , ... ...
Cached Biology Technology:GSI Group Inc. to Restate Financial Results for 2006 2Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics 2Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer 2
Red Standard is sodium salt of resorufin....
Human Jagged 2 Biotinylated Affinity Purified PAb...
RayBio L Series 507: RayBio Label-based Antibody Array I (2 membranes) Class: Antibody Array Products Product Group: Antibody Array...
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
Biology Products: